Trainers' Blog


Pierluigi Navarra, Professor at Università Cattolica da Roma

“The Course “Preclinical and clinical drug development” is a second-level Master according to the Italian academic rules. From the outset in 2006 we are following the EFPIA and PharmaTrain syllabi, all the time attempting to provide our students with the educational criteria of European Pharmaceutical Medicine though such discipline is not formally recognized in Italy. During this time, our course had a great success with an average of 35 students per year – this year a peak of 46 students. Perhaps at variance with other PharmaTrain Courses, the great majority of our students are young people preparing for their first job. We carry out an on-going survey to follow-up our students after their degree and we are pretty proud to see that 95% of our past students are currently employed, in most cases because of the Master title.


Sam Salek, Director, Postgraduate Course in Pharmaceutical Medicine, Cardiff University

“Newly employed physicians can develop their full potential in their recently chosen discipline only by receiving a structured training in medicines development. By attending a training course they start to understand the complexity of the industry and the fascination and variety of the job. An often- quotet and extremely valuable additional benefit is the networking with the faculty and other trainees. The Cardiff Diploma Course was the very first formal training in medicines development/ pharmaceutical medicine starting in 1978. So we celebrate the 35th Anniversary this year – and the new recognition as PharmaTrain Centre of Excellence!

Semmelweis University (SE) is one of participating University Centres that established the first Diploma Course in Medicines Development (DiMD) using the PharmaTrain shared standards. SE now extends the Course with another six Modules, incl. two Electives, to a full Master of Medicines Development (MMD) in cooperation with other universities, the Cooperative European Medicines Development Course (CEMDC).

Sándor Kerpel- Fronius, SE, Budapest

“We are ready to provide a platform to strengthen your competence in bringing a medicine from molecule to market, what we call integrated medicines development.”


Brian Gennery, King’s College, London UK

"King’s College, London is an enthusiastic partner in PharmaTrain and is implementing an integrated course in Drug Development Sciences modelled on the PharmaTrain Syllabus. Teaching is done at the Guy’s or Waterloo Campus with a balanced mixture of academic and industry experts. As much as possible is taught by syndicate project work where students have to work cooperatively on a programme throughout the module, e.g. in the clinical trial module they have to decide which indication to develop and then design a phase 2 study. They then get the data back and have to carry out a statistical analysis and present it back. This allows the students to experience real world problems and work on solutions under the guidance of the teaching staff."



Annette Mollet, ECPM University of Basel, Switzerland

“The European Center of Pharmaceutical Medicine (ECPM) at the University of  Basel is providing training in pharmaceutical medicine since 1991. We are participating in the PharmaTrain project with the clear goal to join forces within this Europe-wide network of partners. Together we will reach a new level of top class postgraduate education covering all aspects of medicines development. ECPM’s teaching programme is a mix of face-to-face lectures and exchange with top specialists worldwide representing pharmaceutical industry, academia and regulatory authorities. To deepen this knowledge participants are immersed into elaboration of possible solutions to cases
originating in the real world of drug development. Training is enhanced and blended with a new e-learning concept.”


Ingrid Klingmann, Deputy Coordinator of PharmaTrain project, European Forum for Good Clinical Practices EFGCP

“Development of new medicines is extremely complex. It requires highly skilled experts in many disciplines who have state-of-the-art knowledge and can reliably contribute to enhance quality and efficiency of this process, based on their thorough education, their experience at the workplace and permanently updated know-how. In addition to the academic training in Universities Learned Societies can support lifelong personal development with practice-oriented training courses delivered by their highly experienced members. Therefore PharmaTrain combines training by Universities and Learned Societies.”

Behrouz KASSAI, MD, PhD, Pediatric Clinical Research and Investigation Centre, Lyon, FRANCE

 “European Diploma In Pharmaceutical Medicine is a second-level Master according to the French academic rules accrediting 90 ECTS. The faculty comprises members from academia and industry from Europe and USA with experience in drug development. Since 2003, 15 students are enrolled each year. The program follows the Pharmatrain Syllabus and has been recognized as a centre of excellence in 2013. Each group of 3 students are tutored by a senior academic. During the first 6 months, they develop a case-study with their tutors and work on a specific topic concerning the drug development process. Their work is systematically presented at DIA European meeting. Students are offered during the second semester an internship with a placement in industry, CROs or academic hospitals. Students benefit also from the excellent environment offered by the city of Lyon.